ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 227 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,680,199 | -16.6% | 6,570,939 | +2.9% | 0.43% | -5.1% |
| Q2 2023 | $42,773,115 | -4.2% | 6,384,047 | +19.9% | 0.45% | -12.6% |
| Q1 2023 | $44,656,077 | +9.6% | 5,322,536 | -0.6% | 0.52% | -12.3% |
| Q4 2022 | $40,731,117 | +22.5% | 5,352,315 | +10.6% | 0.59% | +38.1% |
| Q3 2022 | $33,238,000 | -8.0% | 4,838,191 | +4.8% | 0.42% | -4.7% |
| Q2 2022 | $36,116,000 | -36.1% | 4,618,399 | +11.5% | 0.45% | +7.5% |
| Q1 2022 | $56,522,000 | -35.1% | 4,140,778 | +31.0% | 0.42% | -9.4% |
| Q4 2021 | $87,052,000 | +30.3% | 3,160,923 | +55.9% | 0.46% | +59.6% |
| Q3 2021 | $66,826,000 | -6.3% | 2,027,478 | +13.8% | 0.29% | +2.9% |
| Q2 2021 | $71,289,000 | +344.0% | 1,782,219 | +346.9% | 0.28% | +253.2% |
| Q1 2021 | $16,056,000 | +20.8% | 398,810 | +77.4% | 0.08% | +5.3% |
| Q4 2020 | $13,294,000 | +70.2% | 224,819 | +18.0% | 0.08% | +8.7% |
| Q3 2020 | $7,809,000 | +10.9% | 190,463 | +14.3% | 0.07% | -25.0% |
| Q2 2020 | $7,039,000 | – | 166,573 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |